88IV - PR Newswire Asia's news - Biotechnology

< Previous page

| Title only | Print

Next page >

CARsgen Submitted Responses to FDA Observations SHANGHAI , April 29, 2024 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies ... 2024-04-29T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Henlius Trastuzumab Receives FDA Approval in the United States SHANGHAI , April 29, 2024 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced that the company's business partner, Accord BioPharma Inc. (the U.S. specialty division of Intas Pharmaceuticals, ... 2024-04-29T Banking/Financial Service Biotechnology Health Care/Hospital Medical/Pharmaceuticals
YS Biopharma Receives Additional 180 Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule GAITHERSBURG, Md. , April 29, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd. (Nasdaq: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, ... 2024-04-29T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Technoderma Medicines Advances TDM-180935 Atopic Dermatitis Clinical Program with Phase 2 Trial CHENGDU, China , April 29, 2024 /PRNewswire/ -- Technoderma Medicines, Inc. ("the Company"), a clinical stage biopharmaceutical company, is pleased ... 2024-04-29T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
YS Biopharma Receives Additional 180 Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule GAITHERSBURG, Md. , April 29, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd. (Nasdaq: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, ... 2024-04-29T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
WuXi AppTec Achieved First Quarter 2024 Target Despite External Challenges, Maintaining Stable Operations Revenue Reached RMB7,982 Million ; Excluding COVID-19 Commercial Projects, Down 1.8% Net Profit Attributable to the Owners of the Company Reached RMB1,942 Million ; Diluted Earnings per Share (EPS) ... 2024-04-29T Banking/Financial Service Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Angel Yeast Publishes 2023 Corporate Social Responsibility Report SHANGHAI , April 29, 2024 /PRNewswire/ -- Angel Yeast , (SH600298), the world's leading yeast manufacturer, has released its 2023 CSR Report (the "Report"). The Report highlights the ... 2024-04-29T Biotechnology Environmental Products & Services Food/Beverages Health Care/Hospital
DP Technology DevDay 2024 Showcases Large Science Models and Announces Open Science Initiative BEIJING , April 29, 2024 /PRNewswire/ -- In recent years, the rapid development of artificial intellig ence has introduced new possibilities across numerous scientific disciplines. As an AI for Science ... 2024-04-29T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Prota Therapeutics' CEO Mimi Tang honoured at BioMelbourne Network's Women in Leadership Awards 2024 MELBOURNE, Australia , April 29, 2024 /PRNewswire/ -- Prota Therapeutics ' CEO Professor Mimi Tang has been honoured in the prestigious 2024 BioMelbourne Network Women in Leadership Awards. Professor ... 2024-04-29T Biotechnology Health Care/Hospital
Ractigen Therapeutics Announces FDA Approval for RAG-01, a First-in-Class saRNA Therapy for BCG-Unresponsive NMIBC SUZHOU, China , April 26, 2024 /PRNewswire/ -- Ractigen Therapeutics, a leader in the development of small activating RNA (saRNA) therapeutics, announced today that the U.S. Food and Drug Administration ... 2024-04-26T Biotechnology Health Care/Hospital Medical/Pharmaceuticals

Next page >

88iv | Home | Login

Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer

Copyright (C) 2024

Suntek Computer Systems Limited.

All rights reserved